Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06381141 · ClinicalTrials.gov registry record · Phase 1

A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma

A Phase 1 study of Multiple Myeloma, sponsored by Cullinan Therapeutics.

Active
Registry status
Phase 1
Development phase
30
Enrollment target
8
Study locations

NCT06381141 is a Phase 1 study of Multiple Myeloma that is active but no longer recruiting, run by Cullinan Therapeutics. The registered enrollment target is 30 participants, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (95% lower). The trial reports 8 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06381141, a Phase 1 study of Multiple Myeloma, is active but no longer recruiting, sponsored by Cullinan Therapeutics.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
30 participants
Enrollment target
8
Study locations

Study Summary

A Phase 1b, Multicenter, Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (anti-MICA/MICB Antibody) in Patients with Relapsed and Refractory Multiple Myeloma

Conditions Studied

Multiple Myeloma

Interventions

  • DRUG CLN-619

Study Locations (8)

New York

  • Mt. Sinai - New York
  • Memorial Sloan Kettering (MSK) - New York

North Carolina

  • Levine Cancer Institute - Charlotte
  • Levine Cancer Institute - Winston-Salem

Arizona

  • Mayo Clinic - Phoenix

Florida

  • Mayo Clinic - Jacksonville

Minnesota

  • Mayo Clinic - Rochester

Texas

  • University of Texas Southwestern Medical Center - Dallas

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-09-03
Est. Completion 2027-03
Phase Phase 1

Sponsor

Cullinan Therapeutics

9 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06381141

The ClinicalTrials.gov registry entry for NCT06381141 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 547-participant average among 438 other Multiple Myeloma trials with a reported enrollment target (95% lower). The listed sponsor is Cullinan Therapeutics, which has 9 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Myeloma appearing as the primary indexed condition, and to 1 intervention - of which CLN-619 is the first listed.

NCT06381141 reports 8 study locations spanning 6 distinct geographic areas - top geographies include New York, North Carolina, Arizona.

Frequently Asked Questions

What is clinical trial NCT06381141 about?

NCT06381141 is a clinical study titled "A Study of CLN-619 (Anti-MICA/MICB Antibody) in Patients With Relapsed and Refractory Multiple Myeloma". A Phase 1b, Multicenter, Open-Label, Study to Investigate the Safety and Efficacy of CLN-619 (anti-MICA/MICB Antibody) in Patients with Relapsed and Refractory Multiple Myeloma

What is the current status of trial NCT06381141?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2024-09-03. Estimated completion is 2027-03.

What conditions does trial NCT06381141 study?

This clinical trial studies the following conditions: Multiple Myeloma.

What interventions are being tested in trial NCT06381141?

The interventions under investigation include: CLN-619 (DRUG).

Who is sponsoring clinical trial NCT06381141?

This trial is sponsored by Cullinan Therapeutics, which has 9 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06381141 being conducted?

This trial has 8 study locations across Arizona, Florida, Minnesota, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Myeloma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Myeloma

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.